How the Type of Antiplatelet Agents Can Impact Patient Outcomes

Conference|ASHP Midyear Clinical Meeting and Exhibition - American Society of Health System Pharmacists Midyear Clinical Meeting and Exhibition

Christopher Betz, PharmD, BCPS, FKSHP, FASHP, professor in the department of clinical and administrative sciences at Sullivan University College of Pharmacy, discusses how the type of antiplatelet agent chosen can impact patient outcomes.

This video was recorded at the 2015 American Society of Health-System Pharmacists Midyear Meeting.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

How the Type of Antiplatelet Agents Can Impact Patient Outcomes

Newsletter